ACTINIUM PHARMACEUTICALS, INC. (ATNM) Operating cash flow 2016–2025
ACTINIUM PHARMACEUTICALS, INC. (ATNM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.6MFY2025 · since FY2016: -$20.8M → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +25.7% |
| FY2024 | -$33.1M | +30.1% |
| FY2023 | -$47.3M | -647.6% |
| FY2022 | $8.6M | +141.4% |
| FY2021 | -$20.9M | +3.5% |
| FY2020 | -$21.6M | -0.7% |
| FY2019 | -$21.5M | -4.3% |
| FY2018 | -$20.6M | +4.6% |
| FY2017 | -$21.6M | -3.7% |
| FY2016 | -$20.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice